Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nat Methods ; 21(3): 406-410, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38253843

RESUMEN

The discovery of the bioluminescence pathway in the fungus Neonothopanus nambi enabled engineering of eukaryotes with self-sustained luminescence. However, the brightness of luminescence in heterologous hosts was limited by performance of the native fungal enzymes. Here we report optimized versions of the pathway that enhance bioluminescence by one to two orders of magnitude in plant, fungal and mammalian hosts, and enable longitudinal video-rate imaging.


Asunto(s)
Eucariontes , Luminiscencia , Animales , Mamíferos
2.
Nat Biomed Eng ; 8(2): 193-200, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37996615

RESUMEN

Owing to the immunogenicity of adeno-associated viruses (AAVs), gene therapies using AAVs face considerable obstacles. Here, by leveraging ex vivo T-cell assays, the prediction of epitope binding to major histocompatibility complex class-II alleles, sequence-conservation analysis in AAV phylogeny and site-directed mutagenesis, we show that the replacement of amino acid residues in a promiscuous and most immunodominant T-cell epitope in the AAV9 capsid with AAV5 sequences abrogates the immune responses of peripheral blood mononuclear cells to the chimaeric vector while preserving its functions, potency, cellular specificity, transduction efficacy and biodistribution. This rational approach to the immunosilencing of capsid epitopes promiscuously binding to T cells may be applied to other AAV vectors and epitope regions.


Asunto(s)
Cápside , Dependovirus , Cápside/química , Cápside/metabolismo , Dependovirus/genética , Epítopos de Linfocito T/genética , Epítopos de Linfocito T/análisis , Epítopos de Linfocito T/metabolismo , Leucocitos Mononucleares , Distribución Tisular , Proteínas de la Cápside/genética , Proteínas de la Cápside/química , Proteínas de la Cápside/metabolismo
3.
Org Biomol Chem ; 17(46): 9906-9912, 2019 11 27.
Artículo en Inglés | MEDLINE | ID: mdl-31720665

RESUMEN

Collagen is an abundant component of the extracellular matrix and connective tissues. Some collagen-mimetic peptides (CMPs) that do not form homotrimers can anneal to damaged tissue. Here, through a computational screen, we identify (flpHypGly)7 as an optimal monomeric CMP for heterotrimer formation. We find that (flpHypGly)7 forms stable triple helices with (ProProGly)7 but not with itself. The nonnatural amino acid HflpOH, which is (2S,4S)-4-fluoroproline, is not toxic to human fibroblasts or keratinocytes. Conjugation of (flpHypGly)7 to a fluorescent dye enables the facile detection of burned collagenous tissue with high specificity. The ubiquity of collagen and the prevalence of injuries and diseases that disrupt endogenous collagen suggests widespread utility for this approach.


Asunto(s)
Quemaduras/diagnóstico , Colágeno/química , Péptidos/química , Humanos , Modelos Moleculares
4.
J Biol Chem ; 294(41): 15095-15103, 2019 10 11.
Artículo en Inglés | MEDLINE | ID: mdl-31431502

RESUMEN

The angiogenin (ANG) gene is mutated frequently in individuals with amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. Delivering human ANG to mice that display ALS-like symptoms extends their lifespan and improves motor function. ANG is a secretory vertebrate RNase that enters neuronal cells and cleaves a subset of tRNAs, leading to the inhibition of translation initiation and the assembly of stress granules. Here, using murine neuronal and astrocytic cell lines, we find that ANG triggers the activation of the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, which provides a critical cellular defense against oxidative stress. This activation, which occurred in astrocytes but not in neurons, promoted the survival of proximal neurons that had oxidative injury. These findings extend the role of ANG as a neuroprotective agent and underscore its potential utility in ALS management.


Asunto(s)
Elementos de Respuesta Antioxidante/efectos de los fármacos , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Neuronas/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Ribonucleasa Pancreática/farmacología , Animales , Astrocitos/citología , Línea Celular , Ratones , Neuronas/citología , Neuronas/metabolismo , Fármacos Neuroprotectores/farmacología , Transducción de Señal/efectos de los fármacos
5.
Mol Cancer Ther ; 17(12): 2622-2632, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30282811

RESUMEN

Pancreatic-type ribonucleases (ptRNases) are prevalent secretory enzymes that catalyze the cleavage of RNA. Ribonuclease inhibitor (RI) is a cytosolic protein that has femtomolar affinity for ptRNases, affording protection from the toxic catalytic activity of ptRNases, which can invade human cells. A human ptRNase variant that is resistant to inhibition by RI is a cytotoxin that is undergoing a clinical trial as a cancer chemotherapeutic agent. We find that the ptRNase and protein kinases in the ERK pathway exhibit strongly synergistic toxicity toward lung cancer cells (including a KRASG12C variant) and melanoma cells (including BRAFV600E variants). The synergism arises from inhibiting the phosphorylation of RI and thereby diminishing its affinity for the ptRNase. These findings link seemingly unrelated cellular processes, and suggest that the use of a kinase inhibitor to unleash a cytotoxic enzyme could lead to beneficial manifestations in the clinic.


Asunto(s)
Sistema de Señalización de MAP Quinasas , Mutación/genética , Neoplasias/patología , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/toxicidad , Ribonucleasas/antagonistas & inhibidores , Ribonucleasas/genética , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Sinergismo Farmacológico , Células HEK293 , Humanos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Modelos Biológicos , Fosforilación/efectos de los fármacos , Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores , Proteínas Proto-Oncogénicas B-raf/metabolismo , Proteínas Proto-Oncogénicas p21(ras)/antagonistas & inhibidores , Especificidad por Sustrato/efectos de los fármacos
6.
RNA ; 24(8): 1018-1027, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29748193

RESUMEN

Angiogenin (ANG) is a secretory ribonuclease that promotes the proliferation of endothelial cells, leading to angiogenesis. This function relies on its ribonucleolytic activity, which is low for simple RNA substrates. Upon entry into the cytosol, ANG is sequestered by the ribonuclease inhibitor protein (RNH1). We find that ANG is a potent cytotoxin for RNH1-knockout HeLa cells, belying its inefficiency as a nonspecific catalyst. The toxicity does, however, rely on the ribonucleolytic activity of ANG and a cytosolic localization, which lead to the accumulation of particular tRNA fragments (tRFs), such as tRF-5 Gly-GCC. These up-regulated tRFs are highly cytotoxic at physiological concentrations. Although ANG is well-known for its promotion of cell growth, our results reveal that ANG can also cause cell death.


Asunto(s)
Proteínas Portadoras/metabolismo , Muerte Celular/fisiología , Citotoxinas/metabolismo , ARN de Transferencia/genética , Ribonucleasa Pancreática/metabolismo , Sistemas CRISPR-Cas , Proteínas Portadoras/genética , Muerte Celular/genética , Línea Celular Tumoral , Proliferación Celular , Citotoxinas/genética , Técnicas de Inactivación de Genes , Células HeLa , Humanos , MicroARNs/genética , Estrés Oxidativo , Unión Proteica/genética , Ribonucleasa Pancreática/genética
7.
J Am Chem Soc ; 139(23): 8029-8037, 2017 06 14.
Artículo en Inglés | MEDLINE | ID: mdl-28505435

RESUMEN

The ability to achieve predictable control over the polarization of strained cycloalkynes can influence their behavior in subsequent reactions, providing opportunities to increase both rate and chemoselectivity. A series of new heterocyclic strained cyclooctynes containing a sulfamate backbone (SNO-OCTs) were prepared under mild conditions by employing ring expansions of silylated methyleneaziridines. SNO-OCT derivative 8 outpaced even a difluorinated cyclooctyne in a 1,3-dipolar cycloaddition with benzylazide. The various orbital interactions of the propargylic and homopropargylic heteroatoms in SNO-OCT were explored both experimentally and computationally. The inclusion of these heteroatoms had a positive impact on stability and reactivity, where electronic effects could be utilized to relieve ring strain. The choice of the heteroatom combinations in various SNO-OCTs significantly affected the alkyne geometries, thus illustrating a new strategy for modulating strain via remote substituents. Additionally, this unique heteroatom activation was capable of accelerating the rate of reaction of SNO-OCT with diazoacetamide over azidoacetamide, opening the possibility of further method development in the context of chemoselective, bioorthogonal labeling.


Asunto(s)
Cicloparafinas/síntesis química , Ácidos Sulfónicos/química , Cicloparafinas/química , Electrones , Estructura Molecular , Teoría Cuántica
8.
Angew Chem Int Ed Engl ; 56(10): 2619-2622, 2017 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-28120377

RESUMEN

Angiogenin (ANG) is a human ribonuclease that is compromised in patients with amyotrophic lateral sclerosis (ALS). ANG also promotes neovascularization, and can induce hemorrhage and encourage tumor growth. The causal neurodegeneration of ALS is associated with reactive oxygen species, which are also known to elicit the oxidative cleavage of carbon-boron bonds. We have developed a synthetic boronic acid mask that restrains the ribonucleolytic activity of ANG. The masked ANG does not stimulate endothelial cell proliferation but protects astrocytes from oxidative stress. By differentiating between the two dichotomous biological activities of ANG, this strategy could provide a viable pharmacological approach for the treatment of ALS.


Asunto(s)
Esclerosis Amiotrófica Lateral/tratamiento farmacológico , Ácidos Borónicos/farmacología , Neovascularización Patológica/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Especies Reactivas de Oxígeno/metabolismo , Ribonucleasa Pancreática/farmacología , Esclerosis Amiotrófica Lateral/metabolismo , Esclerosis Amiotrófica Lateral/patología , Ácidos Borónicos/química , Proliferación Celular/efectos de los fármacos , Humanos , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Fármacos Neuroprotectores/química , Estrés Oxidativo/efectos de los fármacos , Ribonucleasa Pancreática/química
9.
Nucleic Acids Res ; 45(2): 818-831, 2017 01 25.
Artículo en Inglés | MEDLINE | ID: mdl-27915233

RESUMEN

Canonical growth factors act indirectly via receptor-mediated signal transduction pathways. Here, we report on an autonomous pathway in which a growth factor is internalized, has its localization regulated by phosphorylation, and ultimately uses intrinsic catalytic activity to effect epigenetic change. Angiogenin (ANG), a secreted vertebrate ribonuclease, is known to promote cell proliferation, leading to neovascularization as well as neuroprotection in mammals. Upon entering cells, ANG encounters the cytosolic ribonuclease inhibitor protein, which binds with femtomolar affinity. We find that protein kinase C and cyclin-dependent kinase phosphorylate ANG, enabling ANG to evade its inhibitor and enter the nucleus. After migrating to the nucleolus, ANG cleaves promoter-associated RNA, which prevents the recruitment of the nucleolar remodeling complex to the ribosomal DNA promoter. The ensuing derepression of rDNA transcription promotes cell proliferation. The biochemical basis for this unprecedented mechanism of signal transduction suggests new modalities for the treatment of cancers and neurological disorders.


Asunto(s)
Proliferación Celular , Ribonucleasa Pancreática/metabolismo , Núcleo Celular/metabolismo , Proteínas Cromosómicas no Histona/metabolismo , Células HeLa , Células Endoteliales de la Vena Umbilical Humana , Humanos , Modelos Biológicos , Modelos Moleculares , Conformación de Ácido Nucleico , Fosforilación , Conformación Proteica , Proteína Quinasa C/metabolismo , Transporte de Proteínas , División del ARN , ARN Ribosómico/genética , ARN Ribosómico/metabolismo , Ribonucleasa Pancreática/química , Transducción de Señal , Transcripción Genética
10.
Chem Biol ; 20(4): 614-8, 2013 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-23601650

RESUMEN

Endocytosis is a fundamental process of eukaryotic cells that is critical for nutrient uptake, signal transduction, and growth. We have developed a molecular probe to quantify endocytosis. The probe is a lipid conjugated to a fluorophore that is masked with an enzyme-activatable moiety known as the trimethyl lock. The probe is not fluorescent when incorporated into the plasma membrane of human cells but becomes fluorescent upon internalization into endosomes, where cellular esterases activate the trimethyl lock. Using this probe, we found that human breast cancer cells undergo constitutive endocytosis more rapidly than do matched noncancerous cells. These data reveal a possible phenotypic distinction of cancer cells that could be the basis for chemotherapeutic intervention.


Asunto(s)
Endocitosis , Fluoresceínas/metabolismo , Colorantes Fluorescentes/metabolismo , Ácidos Fosfatidicos/metabolismo , Urea/análogos & derivados , Línea Celular , Esterasas/metabolismo , Fluoresceínas/síntesis química , Fluoresceínas/química , Colorantes Fluorescentes/síntesis química , Colorantes Fluorescentes/química , Células HeLa , Humanos , Microscopía Fluorescente , Ácidos Fosfatidicos/síntesis química , Ácidos Fosfatidicos/química , Urea/síntesis química , Urea/química , Urea/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...